title: NCI-MATCH launch highlights new trial design in precision-medicine era.
authors.forename: Caroline
authors.initials: C
authors.lastname: McNeil
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards / Q000639:trends; D004273:DNA, Neoplasm / Q000032:analysis; D005820:Genetic Testing; D006801:Humans; D008403:Mass Screening; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends; D009154:Mutation; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D057285:Precision Medicine / Q000379:methods / Q000639:trends; D012107:Research Design / Q000592:standards / Q000639:trends; D017422:Sequence Analysis, DNA; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D004273:DNA, Neoplasm